{"entity":{"id":"preglem","kind":"company","name":"PregLem","aka":["PregLem SA","PregLem S.A."],"tldr":"PregLem is a Geneva biotech, part of Gedeon Richter, whose ulipristal acetate (Esmya) for uterine fibroids went through phase 3 trials it led; it is listed among industry sponsors of cancer-tagged trials.","summary":"PregLem SA, founded in Geneva in 2006 and later acquired by the Hungarian group Gedeon Richter, developed ulipristal acetate (Esmya) for the treatment of uterine fibroids, a benign gynaecological tumour. Its phase 3 programme is registered on ClinicalTrials.gov, where the trials fall under the cancer and neoplasm categories that OnCo's sponsor list draws on.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://preglem.com"},{"label":"ClinicalTrials.gov: trials led by PregLem SA","url":"https://clinicaltrials.gov/search?lead=PregLem%20SA"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q30269207"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Geneva","country":"CH","companyType":"biotech","website":"http://preglem.com","founded":2006,"stage":"acquired","investors":[],"funding":[]},"route":"/companies/preglem/","neighbours":{"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}